Rare diseases
Investigational molecules
Locations
Back to France346 clinical trials in Nimes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Phase 3 Study of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy Patients
FranceFranceA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
FranceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
FranceStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
FranceStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
FranceStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
FranceStudy on IPN10200 for Treating Cervical Dystonia in Adults
FranceFranceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
FranceStudy of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on cardiovascular conditions and metabolic disorders, examining new therapeutic approaches for heart and diabetes-related complications.
Studies evaluating novel drug combinations and monitoring strategies to improve patient outcomes.
Advanced research in cancer treatment, with particular focus on innovative therapies for various types of cancer.
Trials exploring new treatment combinations and diagnostic approaches for better patient care.
Comprehensive research into multiple sclerosis and other neurological conditions, testing innovative treatment approaches.
Focus on developing targeted therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
